![]() indicate which drug products are eligible benefits.The purpose of the Drug benefit list is to: Express Scripts Canada provides claims processing and related services under contract to Indigenous Services Canada. The Drug benefit list is available on the Express Scripts Canada NIHB provider and client website. The listed drugs are those primarily used in a home or ambulatory setting. Clamelle is expected to be available in late October 2008.The Drug benefit list is a listing of the drugs provided as a benefit by the Non-Insured Health Benefits (NIHB) Program. The NPA has developed a chlamydia screening service package, which is due to be launched on 11 August 2008. Manufacturer Actavis is working with the NPA on training materials for pharmacists and medicines counter assistants as well as a Clamelle-branded chlamydia test kit. A database of test results will be held, which pharmacists will need to access to confirm the results for index cases. Partner notification contact slips will be used to obtain a supply partners will not need to have a positive test. Pharmacists will be able to sell azithromycin only to individuals with a positive NAAT (nucleic acid amplification test) result and to their sexual partners. This will, we hope, mark the beginning of a new phase of POM-to-P switches.” Who may buy azithromycin? This service has the potential to play an important part in reducing rates of chlamydia.”Ĭolette McCreedy, chief pharmacist at the National Pharmacy Association, said: “The MHRA has demonstrated great confidence in pharmacy by bringing an antibiotic to the P market. This will ensure fast and effective access to treatment. Natika Halil, director of information at the FPA, said: “For people who are already testing themselves at home it is a really positive step forward that the treatment can now also be bought from pharmacies. Reclassifying azithromycin will expand on existing services and improve access to chlamydia screening and treatment for patients.” “Pharmacists already play an important role in the provision of sexual health services, and have done so for many years. Howard Duff, the Royal Pharmaceutical Society’s director for England, said that the decision would mean convenient and effective care for patients. “Making this medicine available from a pharmacy is a real example of how we are progressing, and enabling people to play an active role in taking charge of their own healthcare.” We know many pharmacists are ready for this too. June Raine, director of vigilance and risk management of medicines at the MHRA, said: “The MHRA is keen to support the availability of more medicines over the counter where it is safe to do so, and we wish to move on to new areas, such as prevention and chronic disease management. The drug will be available as Clamelle for people over 16 years of age who have tested positive for chlamydia but have no symptoms, and for their sexual partners. It is the first oral antibiotic to be switched from prescription-only to pharmacy medicine status. Journal of Pharmaceutical Health Services ResearchĪzithromycin is to be made available over the counter to treat asymptomatic chlamydia infection, the Medicines and Healthcare products Regulatory Agency announced today (6 August 2008).International Journal of Pharmacy Practice.Antimicrobial resistance and stewardship. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |